Blood Thinner Might Be Tied to More Deaths

Paper Summary:

The paper discusses the large number of deaths associated with the blood thinner known as Heparin and attributes this to the drug source being one of Chinese origin. The paper places the blame on the FDA on their shortcomings of not efficiently testing drug sources.

Outline:
Summary of issues presented
Description of parties involved
Potential resolutions
Open questions

From the Paper:

"One of the most significant issues with regards to deaths and injuries associated with Heparin is one which involves a blatant oversight on the part of the FDA. The FDA is duty bound to inspect any plant providing ingredients or product that are approved by the FDA. The FDA has admitted that its officials have neglected to inspect, Changzhou SPL, the Chinese plant which provided the heparin utilized by Baxter International, the maker of the heparin in question. The implications of this are such that the failure on the part of the FDA to do its job can be cited for the resulting deaths of what is now estimated to be approximately seventeen ."

Sample of Sources Used:

• Bogdanich, Walt (2008, February 29). Blood Thinner Might Be Tied to More Deaths. The New York Times (online)

More papers on Blood Thinner Might Be Tied to More Deaths:

• Comparison Essay # 120312 : "To Be and To Have" and "The Gleaners and I"
• Creative Essay # 133328 : "How Might Adrian Louis Be Responding to Christopher Columbus?"
• Analytical Essay # 23482 : "Mama Might Be Better Off Dead"

APA Citation:

MLA Citation: